Paracentral Acute Middle Maculopathy Associated with Severe Anti-Mog (Myelin Oligodendrocyte Glycoprotein)-Positive Optic Neuritis

Imagem de Miniatura
Arquivos
art_FERNANDES_Paracentral_Acute_Middle_Maculopathy_Associated_with_Severe_AntiMog_2023.PDF (9.23 MB)
Citações na Scopus
2
Tipo de produção
article
Data de publicação
2023
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
TAYLOR & FRANCIS AS
Autores
Citação
NEURO-OPHTHALMOLOGY, v.47, n.3, p.156-163, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Retinal complications in patients with inflammatory optic neuritis (ON) are generally related to post-infectious neuroretinitis and are considered uncommon in autoimmune/demyelinating ON, whether isolated or caused by multiple sclerosis (MS) or neuromyelitis optica spectrum disorder (NMOSD). More recently, however, cases with retinal complications have been reported in subjects positive for myelin oligodendrocyte glycoprotein (MOG) antibodies. We report a 53-year-old woman presenting with severe bilateral ON associated with a focal area of paracentral acute middle maculopathy (PAMM) in one eye. Visual loss recovered remarkably after high-dose intravenous corticosteroid treatment and plasmapheresis, but the PAMM lesion remained visible on both optical coherence tomography and angiography as an ischaemic lesion affecting the middle layers of the retina. The report emphasises the possible occurrence of retinal vascular complications in MOG-related optic neuritis, an important addition to the diagnosis of, and possible differentiation from, MS-related or NMOSD-related ON.
Palavras-chave
Optic Neuritis, paracentral acute middle maculopathy, myelin oligodendrocyte glycoprotein, neuromyelitis optica spectrum disorder, retinal ischemia
URI
https://observatorio.fm.usp.br/handle/OPI/54726
Referências
  1. Budoff G, 2019, OPHTHALMOLOGY, V126, P1639, DOI 10.1016/j.ophtha.2019.07.004
  2. Chen JJ, 2018, AM J OPHTHALMOL, V195, P8, DOI 10.1016/j.ajo.2018.07.020
  3. Cobo-Calvo A, 2018, NEUROLOGY, V90, pE1858, DOI 10.1212/WNL.0000000000005560
  4. Creese K, 2017, CLIN EXP OPHTHALMOL, V45, P598, DOI 10.1111/ceo.12945
  5. Deschamps R, 2019, ACTA OPHTHALMOL, V97, pE753, DOI 10.1111/aos.14054
  6. Ducloyer JB, 2020, BRIT J OPHTHALMOL, V104, P842, DOI 10.1136/bjophthalmol-2019-314845
  7. Frohman LP, 2003, J NEURO-OPHTHALMOL, V23, P190, DOI 10.1097/00041327-200309000-00002
  8. Jarius S, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0718-0
  9. Kon T, 2018, INTERNAL MED, V57, P3307, DOI 10.2169/internalmedicine.9840-17
  10. Lee AR, 2018, JAMA OPHTHALMOL, V136, DOI 10.1001/jamaophthalmol.2018.2928
  11. Lukewich Mark K, 2022, Retin Cases Brief Rep, V16, P305, DOI 10.1097/ICB.0000000000000977
  12. Mader S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-184
  13. Moura FC, 2015, NEURO-OPHTHALMOLOGY, V39, P285, DOI 10.3109/01658107.2015.1084332
  14. Moura-Coelho N, 2020, GRAEF ARCH CLIN EXP, V258, P2583, DOI 10.1007/s00417-020-04826-1
  15. Nemiroff J, 2016, AM J OPHTHALMOL, V162, P121, DOI 10.1016/j.ajo.2015.10.026
  16. Northey LC, 2015, BRIT J OPHTHALMOL, V99, P1215, DOI 10.1136/bjophthalmol-2014-306168
  17. PARMLEY VC, 1987, ARCH NEUROL-CHICAGO, V44, P1045, DOI 10.1001/archneur.1987.00520220047015
  18. Purvin V, 2011, J NEURO-OPHTHALMOL, V31, P58, DOI 10.1097/WNO.0b013e31820cf78a
  19. Sarraf D, 2013, JAMA OPHTHALMOL, V131, P1275, DOI 10.1001/jamaophthalmol.2013.4056
  20. Sato DK, 2014, NEUROLOGY, V82, P474, DOI 10.1212/WNL.0000000000000101
  21. Scharf J, 2021, PROG RETIN EYE RES, V81, DOI 10.1016/j.preteyeres.2020.100884
  22. Wingerchuk DM, 2015, NEUROLOGY, V85, P177, DOI 10.1212/WNL.0000000000001729
  23. Yu SQ, 2015, AM J OPHTHALMOL, V159, P53, DOI 10.1016/j.ajo.2014.09.027

Coleções
Artigos e Materiais de Revistas Científicas - FM/MOF
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - HC/InRad
Artigos e Materiais de Revistas Científicas - LIM/33
Artigos e Materiais de Revistas Científicas - LIM/44
Carregar mais